Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada.
about
Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic.Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection.Adverse Effects of Direct Acting Antivirals in HIV/HCV Coinfected Patients: A 4-Year Experience in Miami, Florida.From client to co-worker: a case study of the transition to peer work within a multi-disciplinary hepatitis c treatment team in Toronto, CanadaEfficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials
P2860
Q38623266-DDDB9F3E-5339-4457-9444-DBF739352B19Q38661825-AFFFA7D7-7DF7-4BF6-BFDD-E2D3D77B0ABDQ38746105-0961E16C-6A25-46B1-BAC7-5BCCA09439CFQ40082158-35825E1A-98B8-4E62-8333-BBFDA58C5ED6Q40092669-5E80CD4E-5231-43E3-B28B-D4ADF29AB795Q47552560-779DDC19-90EA-41D9-BE9D-C54404809C29Q55404957-FDE8B735-3821-47E5-B2C5-B261108C3911Q58782699-DC84153B-D840-40B7-8E77-EE7098B05C76Q59133541-6E8A2598-39E5-4B3B-8612-AED30DBDA318
P2860
Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Understanding real-world adher ...... ed program in Toronto, Canada.
@en
type
label
Understanding real-world adher ...... ed program in Toronto, Canada.
@en
prefLabel
Understanding real-world adher ...... ed program in Toronto, Canada.
@en
P2093
P1476
Understanding real-world adher ...... ed program in Toronto, Canada.
@en
P2093
Bernadette Lettner
Jason Altenberg
Jeff Powis
John Matelski
Kate Mason
Mary Guyton
Paula Tookey
P356
10.1016/J.DRUGPO.2017.05.025
P577
2017-06-12T00:00:00Z